BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jacobson KA, Paoletta S, Katritch V, Wu B, Gao ZG, Zhao Q, Stevens RC, Kiselev E. Nucleotides Acting at P2Y Receptors: Connecting Structure and Function. Mol Pharmacol 2015;88:220-30. [PMID: 25837834 DOI: 10.1124/mol.114.095711] [Cited by in Crossref: 65] [Cited by in F6Publishing: 64] [Article Influence: 9.3] [Reference Citation Analysis]
Number Citing Articles
1 Dai QQ, Wang YY, Jiang YP, Li L, Wang HJ. VSNL1 Promotes Gastric Cancer Cell Proliferation and Migration by Regulating P2X3/P2Y2 Receptors and Is a Clinical Indicator of Poor Prognosis in Gastric Cancer Patients. Gastroenterol Res Pract 2020;2020:7241942. [PMID: 33376484 DOI: 10.1155/2020/7241942] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Li Q, Wang C, Mou Z. Perception of Damaged Self in Plants. Plant Physiol 2020;182:1545-65. [PMID: 31907298 DOI: 10.1104/pp.19.01242] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 5.5] [Reference Citation Analysis]
3 Puchałowicz K, Baranowska-Bosiacka I, Dziedziejko V, Chlubek D. Purinergic signaling and the functioning of the nervous system cells. Cell Mol Biol Lett 2015;20:867-918. [PMID: 26618572 DOI: 10.1515/cmble-2015-0050] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
4 Jiang J, Yu C, Guo X, Zhang H, Tian S, Cai K, He Z, Sun C. G Protein-Coupled Receptor GPR87 Promotes the Expansion of PDA Stem Cells through Activating JAK2/STAT3. Mol Ther Oncolytics 2020;17:384-93. [PMID: 32405536 DOI: 10.1016/j.omto.2020.01.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
5 von Kügelgen I. Structure, Pharmacology and Roles in Physiology of the P2Y12 Receptor. Adv Exp Med Biol 2017;1051:123-38. [PMID: 28921447 DOI: 10.1007/5584_2017_98] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
6 Ferrari D, Malavasi F, Antonioli L. A Purinergic Trail for Metastases. Trends Pharmacol Sci 2017;38:277-90. [PMID: 27989503 DOI: 10.1016/j.tips.2016.11.010] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
7 Fleck D, Kenzler L, Mundt N, Strauch M, Uesaka N, Moosmann R, Bruentgens F, Missel A, Mayerhofer A, Merhof D, Spehr J, Spehr M. ATP activation of peritubular cells drives testicular sperm transport. Elife 2021;10:e62885. [PMID: 33502316 DOI: 10.7554/eLife.62885] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
8 Roy B, Depaix A, Périgaud C, Peyrottes S. Recent Trends in Nucleotide Synthesis. Chem Rev 2016;116:7854-97. [PMID: 27319940 DOI: 10.1021/acs.chemrev.6b00174] [Cited by in Crossref: 92] [Cited by in F6Publishing: 68] [Article Influence: 15.3] [Reference Citation Analysis]
9 Pfaffenzeller MS, Franciosi MLM, Cardoso AM. Purinergic signaling and tumor microenvironment in cervical Cancer. Purinergic Signal 2020;16:123-35. [PMID: 32170538 DOI: 10.1007/s11302-020-09693-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
10 Rajagopal S, Ponnusamy M. P2Y Receptor. Metabotropic GPCRs: TGR5 and P2Y Receptors in Health and Diseases. Singapore: Springer; 2018. pp. 39-55. [DOI: 10.1007/978-981-13-1571-8_3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
11 Beamer E, Gölöncsér F, Horváth G, Bekő K, Otrokocsi L, Koványi B, Sperlágh B. Purinergic mechanisms in neuroinflammation: An update from molecules to behavior. Neuropharmacology 2016;104:94-104. [PMID: 26384652 DOI: 10.1016/j.neuropharm.2015.09.019] [Cited by in Crossref: 58] [Cited by in F6Publishing: 56] [Article Influence: 8.3] [Reference Citation Analysis]
12 Neumann J, Hofmann B, Gergs U. On inotropic effects of UTP in the human heart. Heliyon 2019;5:e02197. [PMID: 31406941 DOI: 10.1016/j.heliyon.2019.e02197] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
13 Babou Kammoe RB, Kauffenstein G, Pelletier J, Robaye B, Sévigny J. NTPDase1 Modulates Smooth Muscle Contraction in Mice Bladder by Regulating Nucleotide Receptor Activation Distinctly in Male and Female. Biomolecules 2021;11:147. [PMID: 33498759 DOI: 10.3390/biom11020147] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Novitskaya T, Chepurko E, Covarrubias R, Novitskiy S, Ryzhov SV, Feoktistov I, Gumina RJ. Extracellular nucleotide regulation and signaling in cardiac fibrosis. J Mol Cell Cardiol 2016;93:47-56. [PMID: 26891859 DOI: 10.1016/j.yjmcc.2016.02.010] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
15 Jacobson KA, Delicado EG, Gachet C, Kennedy C, von Kügelgen I, Li B, Miras-Portugal MT, Novak I, Schöneberg T, Perez-Sen R, Thor D, Wu B, Yang Z, Müller CE. Update of P2Y receptor pharmacology: IUPHAR Review 27. Br J Pharmacol 2020;177:2413-33. [PMID: 32037507 DOI: 10.1111/bph.15005] [Cited by in Crossref: 52] [Cited by in F6Publishing: 51] [Article Influence: 26.0] [Reference Citation Analysis]
16 Jin H, Ko YS, Park SW, Kim HJ. P2Y2R activation by ATP induces oxLDL-mediated inflammasome activation through modulation of mitochondrial damage in human endothelial cells. Free Radic Biol Med 2019;136:109-17. [PMID: 30959169 DOI: 10.1016/j.freeradbiomed.2019.04.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
17 Jacobson KA, Müller CE. Medicinal chemistry of adenosine, P2Y and P2X receptors. Neuropharmacology. 2016;104:31-49. [PMID: 26686393 DOI: 10.1016/j.neuropharm.2015.12.001] [Cited by in Crossref: 139] [Cited by in F6Publishing: 127] [Article Influence: 19.9] [Reference Citation Analysis]
18 Carracedo G, Crooke A, Guzman-Aranguez A, Pérez de Lara MJ, Martin-Gil A, Pintor J. The role of dinucleoside polyphosphates on the ocular surface and other eye structures. Prog Retin Eye Res 2016;55:182-205. [PMID: 27421962 DOI: 10.1016/j.preteyeres.2016.07.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
19 Jiang LH, Mousawi F, Yang X, Roger S. ATP-induced Ca2+-signalling mechanisms in the regulation of mesenchymal stem cell migration. Cell Mol Life Sci. 2017;74:3697-3710. [PMID: 28534085 DOI: 10.1007/s00018-017-2545-6] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 6.0] [Reference Citation Analysis]
20 Li S, Li J, Wang N, Hao G, Sun J. Characterization of UDP-Activated Purinergic Receptor P2Y₆ Involved in Japanese Flounder Paralichthys olivaceus Innate Immunity. Int J Mol Sci 2018;19:E2095. [PMID: 30029501 DOI: 10.3390/ijms19072095] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
21 Gao ZG, Jacobson KA. Purinergic Signaling in Mast Cell Degranulation and Asthma. Front Pharmacol 2017;8:947. [PMID: 29311944 DOI: 10.3389/fphar.2017.00947] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 7.8] [Reference Citation Analysis]
22 Ciancetta A, O'Connor RD, Paoletta S, Jacobson KA. Demystifying P2Y1 Receptor Ligand Recognition through Docking and Molecular Dynamics Analyses. J Chem Inf Model 2017;57:3104-23. [PMID: 29182323 DOI: 10.1021/acs.jcim.7b00528] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
23 Zarrinmayeh H, Territo PR. Purinergic Receptors of the Central Nervous System: Biology, PET Ligands, and Their Applications. Mol Imaging 2020;19:1536012120927609. [PMID: 32539522 DOI: 10.1177/1536012120927609] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 14.0] [Reference Citation Analysis]
24 Appy L, Depaix A, Bantreil X, Lamaty F, Peyrottes S, Roy B. Straightforward Ball-Milling Access to Dinucleoside 5',5'-Polyphosphates via Phosphorimidazolide Intermediates. Chemistry 2019;25:2477-81. [PMID: 30549335 DOI: 10.1002/chem.201805924] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
25 Kavvadas P, Abed A, Poulain C, Authier F, Labéjof LP, Calmont A, Afieri C, Prakoura N, Dussaule JC, Chatziantoniou C, Chadjichristos CE. Decreased Expression of Connexin 43 Blunts the Progression of Experimental GN. J Am Soc Nephrol 2017;28:2915-30. [PMID: 28667079 DOI: 10.1681/ASN.2016111211] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
26 Olotu C, Kiefmann M, Ronneburg C, Lehmensiek F, Cuvenhaus A, Meidl V, Goetz AE, Kiefmann R. Analysis of purine receptor expression and functionality in alveolar epithelial cells. Purinergic Signal 2020;16:213-29. [PMID: 32236789 DOI: 10.1007/s11302-020-09696-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
27 Li S, Wang N, Feng Y, Li J, Geng X, Sun J. Functional characterization of purinergic receptor P2Y14 in the Japanese flounder (Paralichthys olivaceus) head kidney macrophages. Fish Shellfish Immunol 2019;93:200-7. [PMID: 31326587 DOI: 10.1016/j.fsi.2019.07.053] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
28 Gündüz D, Tanislav C, Sedding D, Parahuleva M, Santoso S, Troidl C, Hamm CW, Aslam M. Uridine Triphosphate Thio Analogues Inhibit Platelet P2Y12 Receptor and Aggregation. Int J Mol Sci 2017;18:E269. [PMID: 28146050 DOI: 10.3390/ijms18020269] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
29 Frenguelli BG, Dale N. Purines: From Diagnostic Biomarkers to Therapeutic Agents in Brain Injury. Neurosci Bull 2020;36:1315-26. [PMID: 32542580 DOI: 10.1007/s12264-020-00529-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
30 Degn M, Dauvilliers Y, Dreisig K, Lopez R, Pfister C, Pradervand S, Rahbek Kornum B, Tafti M. Rare missense mutations in P2RY11 in narcolepsy with cataplexy. Brain 2017;140:1657-68. [DOI: 10.1093/brain/awx093] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
31 Di Virgilio F, Giuliani AL. Purinergic signalling in autoimmunity: A role for the P2X7R in systemic lupus erythematosus? Biomed J 2016;39:326-38. [PMID: 27884379 DOI: 10.1016/j.bj.2016.08.006] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.5] [Reference Citation Analysis]
32 Gąsecka A, Rogula S, Eyileten C, Postuła M, Jaguszewski MJ, Kochman J, Mazurek T, Nieuwland R, Filipiak KJ. Role of P2Y Receptors in Platelet Extracellular Vesicle Release. Int J Mol Sci 2020;21:E6065. [PMID: 32842470 DOI: 10.3390/ijms21176065] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
33 Jiang LH, Hao Y, Mousawi F, Peng H, Yang X. Expression of P2 Purinergic Receptors in Mesenchymal Stem Cells and Their Roles in Extracellular Nucleotide Regulation of Cell Functions. J Cell Physiol 2017;232:287-97. [PMID: 27403750 DOI: 10.1002/jcp.25484] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
34 Wang J, Carrillo JJ, Lin HV. GPR142 Agonists Stimulate Glucose-Dependent Insulin Secretion via Gq-Dependent Signaling. PLoS One 2016;11:e0154452. [PMID: 27104960 DOI: 10.1371/journal.pone.0154452] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
35 Alberto AVP, Ferreira NCDS, Bonavita AGC, Nihei OK, Farias FP, Bisaggio RDC, Albuquerque C, Savino W, Coutinho-Silva R, Persechini PM, Alves LA. Physiologic roles of P2 receptors in leukocytes. J Leukoc Biol 2022. [PMID: 35837975 DOI: 10.1002/JLB.2RU0421-226RR] [Reference Citation Analysis]
36 Pacheco PAF, Diogo RT, Magalhães BQ, Faria RX. Plant natural products as source of new P2 receptors ligands. Fitoterapia 2020;146:104709. [DOI: 10.1016/j.fitote.2020.104709] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
37 Ciancetta A, Jacobson KA. Breakthrough in GPCR Crystallography and Its Impact on Computer-Aided Drug Design. Methods Mol Biol 2018;1705:45-72. [PMID: 29188558 DOI: 10.1007/978-1-4939-7465-8_3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
38 Zeng Y, Luo H, Gao Z, Zhu X, Shen Y, Li Y, Hu J, Yang J. Reduction of prefrontal purinergic signaling is necessary for the analgesic effect of morphine. iScience 2021;24:102213. [PMID: 33733073 DOI: 10.1016/j.isci.2021.102213] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Rasool F, Mukherjee D. Pd-Catalyzed Regio- and Stereoselective C -Nucleoside Synthesis from Unactivated Uracils and Pyranoid Glycals. Org Lett 2017;19:4936-9. [DOI: 10.1021/acs.orglett.7b02402] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
40 Paoletta S, Sabbadin D, von Kügelgen I, Hinz S, Katritch V, Hoffmann K, Abdelrahman A, Straßburger J, Baqi Y, Zhao Q, Stevens RC, Moro S, Müller CE, Jacobson KA. Modeling ligand recognition at the P2Y12 receptor in light of X-ray structural information. J Comput Aided Mol Des 2015;29:737-56. [PMID: 26194851 DOI: 10.1007/s10822-015-9858-z] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
41 Dal Ben D, Antonioli L, Lambertucci C, Spinaci A, Fornai M, D'Antongiovanni V, Pellegrini C, Blandizzi C, Volpini R. Approaches for designing and discovering purinergic drugs for gastrointestinal diseases. Expert Opin Drug Discov 2020;15:687-703. [PMID: 32228110 DOI: 10.1080/17460441.2020.1743673] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
42 Qin X, Wang X. Quantification of nucleotides and their sugar conjugates in biological samples: Purposes, instruments and applications. J Pharm Biomed Anal 2018;158:280-7. [PMID: 29902692 DOI: 10.1016/j.jpba.2018.06.013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
43 Chen X, Xiao B, Yang M, Chen M, Xiao Z. Adenosine diphosphate-sensitive P2Y11 receptor inhibits endothelial cell proliferation by induction of cell cycle arrest in the S phase and induces the expression of inflammatory mediators. J Cell Biochem 2018. [PMID: 30144157 DOI: 10.1002/jcb.27482] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
44 Kwon K, Hwang Y, Jung J, Tae G. Enhanced Transport and Permeation of a Polymeric Nanocarrier across the Retina by Mixing with ATP upon Intravitreal Injection. Pharmaceutics 2021;13:463. [PMID: 33805533 DOI: 10.3390/pharmaceutics13040463] [Reference Citation Analysis]
45 Toti KS, Jain S, Ciancetta A, Balasubramanian R, Chakraborty S, Surujdin R, Shi ZD, Jacobson KA. Pyrimidine Nucleotides Containing a (S)-Methanocarba Ring as P2Y6 Receptor Agonists. Medchemcomm 2017;8:1897-908. [PMID: 29423136 DOI: 10.1039/C7MD00397H] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.2] [Reference Citation Analysis]
46 Mahmood A, Iqbal J. Purinergic receptors modulators: An emerging pharmacological tool for disease management. Med Res Rev 2022. [PMID: 35561109 DOI: 10.1002/med.21888] [Reference Citation Analysis]
47 de Araújo JB, Kerkhoff VV, de Oliveira Maciel SFV, de Resende E Silva DT. Targeting the purinergic pathway in breast cancer and its therapeutic applications. Purinergic Signal 2021;17:179-200. [PMID: 33576905 DOI: 10.1007/s11302-020-09760-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Díaz-Muñoz M, Hernández-Muñoz R, Butanda-Ochoa A. Structure-activity features of purines and their receptors: implications in cell physiopathology. Mol Biomed 2022;3:5. [PMID: 35079944 DOI: 10.1186/s43556-022-00068-1] [Reference Citation Analysis]
49 Giri D, Raut SK, Behera CK, Patra SK. Diketopyrrollopyrrole anchored carbazole-alt-thiophene based Fe3+-coordinated metallopolymer for the selective recognition of ATP. Polymer 2022;253:124951. [DOI: 10.1016/j.polymer.2022.124951] [Reference Citation Analysis]
50 Zhang C, Qin J, Zhang S, Zhang N, Tan B, Siwko S, Zhang Y, Wang Q, Chen J, Qian M, Liu M, Du B. ADP/P2Y1 aggravates inflammatory bowel disease through ERK5-mediated NLRP3 inflammasome activation. Mucosal Immunol 2020;13:931-45. [PMID: 32518369 DOI: 10.1038/s41385-020-0307-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
51 Scarpellino G, Genova T, Avanzato D, Bernardini M, Bianco S, Petrillo S, Tolosano E, de Almeida Vieira JR, Bussolati B, Fiorio Pla A, Munaron L. Purinergic Calcium Signals in Tumor-Derived Endothelium. Cancers (Basel) 2019;11:E766. [PMID: 31159426 DOI: 10.3390/cancers11060766] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
52 Alvarez CL, Troncoso MF, Espelt MV. Extracellular ATP and adenosine in tumor microenvironment: Roles in epithelial-mesenchymal transition, cell migration, and invasion. J Cell Physiol 2021. [PMID: 34514618 DOI: 10.1002/jcp.30580] [Reference Citation Analysis]
53 King BF. Purinergic signalling in the enteric nervous system (An overview of current perspectives). Auton Neurosci 2015;191:141-7. [PMID: 26049261 DOI: 10.1016/j.autneu.2015.05.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
54 Engel T, Smith J, Alves M. Targeting Neuroinflammation via Purinergic P2 Receptors for Disease Modification in Drug-Refractory Epilepsy. J Inflamm Res 2021;14:3367-92. [PMID: 34305404 DOI: 10.2147/JIR.S287740] [Reference Citation Analysis]
55 Ding M, Zhan H, Liao X, Li A, Zhong Y, Gao Q, Liu Y, Huang W, Cai Z. Enhancer RNA - P2RY2e induced by estrogen promotes malignant behaviors of bladder cancer. Int J Biol Sci 2018;14:1268-76. [PMID: 30123075 DOI: 10.7150/ijbs.27151] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
56 Trull KJ, Miller P, Tat K, Varney SA, Conley JM, Tantama M. Detection of Osmotic Shock-Induced Extracellular Nucleotide Release with a Genetically Encoded Fluorescent Sensor of ADP and ATP. Sensors (Basel) 2019;19:E3253. [PMID: 31344821 DOI: 10.3390/s19153253] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
57 Zimmermann H. Extracellular ATP and other nucleotides-ubiquitous triggers of intercellular messenger release. Purinergic Signal 2016;12:25-57. [PMID: 26545760 DOI: 10.1007/s11302-015-9483-2] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 6.3] [Reference Citation Analysis]
58 Conner JW, Poole DP, Jörg M, Veldhuis NA. New small molecule fluorescent probes for G protein-coupled receptors: valuable tools for drug discovery. Future Med Chem 2021;13:63-90. [PMID: 33319586 DOI: 10.4155/fmc-2019-0327] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
59 Cacciari B, Crepaldi P, Cheng CY, Bossi E, Spalluto G, Federico S, Jacobson KA, Cattaneo M. Structure Activity Relationship of 4-Amino-2-thiopyrimidine Derivatives as Platelet Aggregation Inhibitors. Med Chem 2019;15:863-72. [PMID: 30734681 DOI: 10.2174/1573406415666190208124534] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
60 Tak E, Jun DY, Kim SH, Park GC, Lee J, Hwang S, Song GW, Lee SG. Upregulation of P2Y2 nucleotide receptor in human hepatocellular carcinoma cells. J Int Med Res 2016;44:1234-47. [PMID: 27807254 DOI: 10.1177/0300060516662135] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
61 Le Duc D, Schulz A, Lede V, Schulze A, Thor D, Brüser A, Schöneberg T. P2Y Receptors in Immune Response and Inflammation. Adv Immunol 2017;136:85-121. [PMID: 28950952 DOI: 10.1016/bs.ai.2017.05.006] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 4.4] [Reference Citation Analysis]
62 Lopes AB, Wagner P, de Souza ROMA, Germain NL, Uziel J, Bourguignon J, Schmitt M, Miranda LSM. Functionalization of 2 H -1,2,3-Triazole C -Nucleoside Template via N 2 Selective Arylation. J Org Chem 2016;81:4540-9. [DOI: 10.1021/acs.joc.6b00323] [Cited by in Crossref: 27] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
63 Kasztan M, Piwkowska A, Kreft E, Rogacka D, Audzeyenka I, Szczepanska-Konkel M, Jankowski M. Extracellular purines' action on glomerular albumin permeability in isolated rat glomeruli: insights into the pathogenesis of albuminuria. Am J Physiol Renal Physiol 2016;311:F103-11. [PMID: 27076649 DOI: 10.1152/ajprenal.00567.2015] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
64 Wirsching E, Fauler M, Fois G, Frick M. P2 Purinergic Signaling in the Distal Lung in Health and Disease. Int J Mol Sci 2020;21:E4973. [PMID: 32674494 DOI: 10.3390/ijms21144973] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
65 Anwar S, Rivest S. Alzheimer's disease: microglia targets and their modulation to promote amyloid phagocytosis and mitigate neuroinflammation. Expert Opin Ther Targets 2020;24:331-44. [PMID: 32129117 DOI: 10.1080/14728222.2020.1738391] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
66 Gao ZG, Jacobson KA. Distinct Signaling Patterns of Allosteric Antagonism at the P2Y1 Receptor. Mol Pharmacol 2017;92:613-26. [PMID: 28864555 DOI: 10.1124/mol.117.109660] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
67 Alves M, Beamer E, Engel T. The Metabotropic Purinergic P2Y Receptor Family as Novel Drug Target in Epilepsy. Front Pharmacol 2018;9:193. [PMID: 29563872 DOI: 10.3389/fphar.2018.00193] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
68 Jacobson KA, IJzerman AP, Müller CE. Medicinal chemistry of P2 and adenosine receptors: Common scaffolds adapted for multiple targets. Biochem Pharmacol 2021;187:114311. [PMID: 33130128 DOI: 10.1016/j.bcp.2020.114311] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
69 Djerada Z, Feliu C, Richard V, Millart H. Current knowledge on the role of P2Y receptors in cardioprotection against ischemia-reperfusion. Pharmacol Res 2017;118:5-18. [PMID: 27520402 DOI: 10.1016/j.phrs.2016.08.009] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]